- CVS launches a new GPO for its PBM
- CMS rethinks copay accumulators
- Here’s how GoodRx makes money
- Supermarkets face pharmacy challenges
P.S. Join the more than 9,500 followers of my curated links to neat stuff at @DrugChannels on Twitter. My recent tweets have highlighted: Amazon’s activities, PillPack’s bad reviews, 340B outrages, rebate reform redux, biosimilar pricing, managed Medicaid market shares, drug pricing, blockchain hype, and the warp speed vs. hyperspace debate.